<DOC>
	<DOCNO>NCT01833195</DOCNO>
	<brief_summary>The objective registry observe short long term clinical outcome heart transplant recipient receive regular AlloMap test part allograft rejection surveillance .</brief_summary>
	<brief_title>Outcomes AlloMap Registry : Long-term Management Outcomes Heart Transplant Recipients With AlloMap Testing</brief_title>
	<detailed_description>The standard care adult heart transplant recipient perform periodic endomyocardial biopsy surveillance rejection . Because risk discomfort associate biopsy procedure , non-invasive test ( AlloMap ) base gene-expression profile peripheral blood develop introduced 2005 identify heart transplant recipient low probability rejection time protocol surveillance test . The schedule AlloMap surveillance test derive customary timing surveillance biopsy : e.g . 1 2 month interval patient 6 12 post-transplantation , 3 , 4 6 month first year post-transplantation . In large multicenter IMAGE ( Invasive Monitoring Attenuation Gene Expression Profiling ) 602 patient United States undergone cardiac transplantation least 6 month prior randomize 1:1 either surveillance routine biopsy AlloMap testing . Patients group also monitor echocardiography . A primary outcome event define episode rejection hemodynamic compromise , graft dysfunction due cause , death retransplantation . Over median follow-up period 19 month , 297 patient monitor AlloMap 305 patient underwent routine biopsy similar 2-year cumulative rate event ( 14.5 % 15.3 % , respectively ; hazard ratio gene-expression profiling , 1.04 ; 95 % confidence interval , 0.67 1.68 ) . This Outcomes AlloMap Registry ( OAR ) study design collect similar clinical outcome information study IMAGE , large cohort patient ( approximately 2000 ) follow 5 year . At routine clinic visit , key clinical feature rejection surveillance management schedule , test result ( e.g . blood level immunosuppressive agent ) , AlloMap score collect . This large long term follow-up dataset intend enable elucidation , analyse technique multivariate Cox proportional hazard model , surveillance management feature may associate contribute favorable long term outcome heart recipient .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>New exist heart transplant recipient ≥ 2 month ( ≥ 55 day ) posttransplant receive posttransplant care enrol center interim surveillance monitoring include AlloMap test</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>molecular diagnostics</keyword>
	<keyword>heart transplantation</keyword>
	<keyword>risk factor</keyword>
	<keyword>prognosis</keyword>
</DOC>